LEGAL PROCEEDINGS AND CONTINGENCIES (Details) $ in Millions |
1 Months Ended | |||||
|---|---|---|---|---|---|---|
|
May 31, 2025
USD ($)
|
May 31, 2024
USD ($)
|
Feb. 28, 2021
USD ($)
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2021
USD ($)
|
Mar. 31, 2018
lawsuit
|
|
| Legal Proceedings and Contingencies [Line Items] | ||||||
| Obligation to holders of the contingent value rights | $ 6,400 | |||||
| Accrued liabilities for CERCLA matters | $ 62 | |||||
| Attorney General of Hawaii v. Bristol-Myers Squibb and Sanofi | ||||||
| Legal Proceedings and Contingencies [Line Items] | ||||||
| Litigation settlement, amount awarded to other party | $ 350 | $ 458 | $ 417 | |||
| Attorney General of Hawaii v. Bristol-Myers Squibb and Sanofi | BMS and Sanofi | ||||||
| Legal Proceedings and Contingencies [Line Items] | ||||||
| Litigation settlement, amount awarded to other party | $ 700 | $ 916 | $ 834 | |||
| Celgene Securities Class Action | ||||||
| Legal Proceedings and Contingencies [Line Items] | ||||||
| Putative claims | lawsuit | 2 | |||||